标题
Lipoxin Signaling in Murine Lung Host Responses toCryptococcus neoformansInfection
作者
关键词
-
出版物
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
Volume 54, Issue 1, Pages 25-33
出版商
American Thoracic Society
发表日期
2015-06-04
DOI
10.1165/rcmb.2014-0102oc
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The Leukotriene B4/BLT1 Axis Is a Key Determinant in Susceptibility and Resistance to Histoplasmosis
- (2014) Adriana Secatto et al. PLoS One
- Resolution phase lipid mediators of inflammation: agonists of resolution
- (2013) Charles N. Serhan et al. CURRENT OPINION IN PHARMACOLOGY
- 5-Lipoxygenase Activity Increases Susceptibility to Experimental Paracoccidioides brasiliensis Infection
- (2013) Fabrine Sales Massafera Tristão et al. INFECTION AND IMMUNITY
- Interleukin-17A Enhances Host Defense against Cryptococcal Lung Infection through Effects Mediated by Leukocyte Recruitment, Activation, and Gamma Interferon Production
- (2013) Benjamin J. Murdock et al. INFECTION AND IMMUNITY
- Resolvin D1 Receptor Stereoselectivity and Regulation of Inflammation and Proresolving MicroRNAs
- (2012) Sriram Krishnamoorthy et al. AMERICAN JOURNAL OF PATHOLOGY
- IL-23 Dampens the Allergic Response to Cryptococcus neoformans through IL-17–Independent and –Dependent Mechanisms
- (2012) Wendy A. Szymczak et al. AMERICAN JOURNAL OF PATHOLOGY
- Resolution of Inflammation in Asthma
- (2012) Bruce D. Levy et al. CLINICS IN CHEST MEDICINE
- 5-Lipoxygenase Deficiency Impairs Innate and Adaptive Immune Responses during Fungal Infection
- (2012) Adriana Secatto et al. PLoS One
- Serum amyloid A opposes lipoxin A4 to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease
- (2012) S. Bozinovski et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Transcriptional regulation of the human FPR2/ALX gene: evidence of a heritable genetic variant that impairs promoter activity
- (2011) Felice Simiele et al. FASEB JOURNAL
- Evidence for an Anti-Inflammatory Loop Centered on Polymorphonuclear Leukocyte Formyl Peptide Receptor 2/Lipoxin A4 Receptor and Operative in the Inflamed Microvasculature
- (2011) V. Brancaleone et al. JOURNAL OF IMMUNOLOGY
- Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
- (2010) John R. Perfect et al. CLINICAL INFECTIOUS DISEASES
- Eosinophils promote resolution of acute peritonitis by producing proresolving mediators in mice
- (2010) Tomohiro Yamada et al. FASEB JOURNAL
- Dichotomy in duration and severity of acute inflammatory responses in humans arising from differentially expressed proresolution pathways
- (2010) T. Morris et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Anti-Inflammatory and Proresolving Mediator Resolvin E1 Protects Mice from Bacterial Pneumonia and Acute Lung Injury
- (2009) H. Seki et al. JOURNAL OF IMMUNOLOGY
- A Functional IL-13 Receptor Is Expressed on Polarized Murine CD4+ Th17 Cells and IL-13 Signaling Attenuates Th17 Cytokine Production
- (2009) D. C. Newcomb et al. JOURNAL OF IMMUNOLOGY
- Airway Lipoxin A4Generation and Lipoxin A4Receptor Expression Are Decreased in Severe Asthma
- (2008) Anna Planagumà et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Inheritance of Immune Polarization Patterns Is Linked to Resistance versus Susceptibility to Cryptococcus neoformans in a Mouse Model
- (2008) G.-h. Chen et al. INFECTION AND IMMUNITY
- Resolvin E1 regulates interleukin 23, interferon-γ and lipoxin A4 to promote the resolution of allergic airway inflammation
- (2008) Oliver Haworth et al. NATURE IMMUNOLOGY
- Acute Lower Respiratory Tract Infection
- (2008) Joseph P. Mizgerd NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started